Here's Why NuVasive Is Tanking Today
After NuVasive (NASDAQ: NUVA), a medical device maker focused on minimally invasive spine surgery, reported mixed second-quarter earnings results and announced a shake-up in its executive team, its shares had fallen 11% as of 11:45 a.m. EDT.
Here's a quick review of the headline numbers from NuVasive's second quarter:
While the slight miss on revenue could help to explain the sell-off, the markets were caught off guard by the announcement of sweeping changes to the company's executive team:
Source: Fool.com
Johnson & Johnson Stock
€224.25
0.110%
With 57 Buy predictions and not a single Sell prediction Johnson & Johnson is an absolute favorite of our community.
As a result the target price of 228 € shows a slightly positive potential of 1.67% compared to the current price of 224.25 € for Johnson & Johnson.
